麦进嘉独家的Blockmir技术
广东麦进嘉生物科技有限公司是一家拥有完全自主知识产权的核酸药物研发平台。该平台将Blockmir技术开发的新药先导化合物及相关子专利授权给各大制药公司。目前，广东麦进嘉生物科技有限公司已拥有这些专利的全球所有权，并继续开发各种疾病领域迫切需要的靶向创新药物。
List of patents owned by MJJ Biotechnologies:
Oligonucleotides for mRNA regulation PCT/DK2007/050174 China
Oligonucleotides for mRNA regulation PCT/DK2007/050174 Japan
Oligonucleotides for mRNA regulation PCT/DK2007/050174 United States
Oligonucleotides for mRNA regulation PCT/DK2007/050174 Europe
Oligonucleotides for mRNA regulation PCT/DK2007/050174 Australia
Oligonucleotides for mRNA regulation PCT/DK2007/050174 Australia
Oligonucleotides for mRNA regulation PCT/DK2007/050174 Canada
Oligonucleotides for mRNA regulation PCT/DK2007/050174 Switzerland
Oligonucleotides for mRNA regulation PCT/DK2007/050174 Germany
Oligonucleotides for mRNA regulation PCT/DK2007/050174 France
Oligonucleotides for mRNA regulation PCT/DK2007/050174 United Kingdom
Oligonucleotides for modulation of target RNA activity PCT/DK2008/050141 Canada
Oligonucleotides for modulation of target RNA activity PCT/DK2008/050141 Switzerland
Oligonucleotides for modulation of target RNA activity PCT/DK2008/050141 Japan
Oligonucleotides for modulation of target RNA activity PCT/DK2008/050141 Australia
Oligonucleotides for modulation of target RNA activity PCT/DK2008/050141 Europe
Oligonucleotides for modulation of target RNA activity PCT/DK2008/050141 United States
Oligonucleotides for modulation of target RNA activity PCT/DK2008/050141 United States
Oligonucleotides for modulation of target RNA activity PCT/DK2008/050141 Switzerland
Oligonucleotides for modulation of target RNA activity PCT/DK2008/050141 Germany
Oligonucleotides for modulation of target RNA activity PCT/DK2008/050141 France
Oligonucleotides for modulation of target RNA activity PCT/DK2008/050141 United Kingdom
Bivalent antisense oligonucleotides PCT/EP2011/054545 United States
Bivalent antisense oligonucleotides PCT/EP2011/054545 Europe
Bivalent antisense oligonucleotides PCT/EP2011/054545 Switzerland
Bivalent antisense oligonucleotides PCT/EP2011/054545 Germany
Bivalent antisense oligonucleotides PCT/EP2011/054545 France
Bivalent antisense oligonucleotides PCT/EP2011/054545 United Kingdom
Further oligonucleotides for modulation of target RNA activity PCT/DK2011/050447 Europe
Further oligonucleotides for modulation of target RNA activity PCT/DK2011/050447 United States
Further oligonucleotides for modulation of target RNA activity PCT/DK2011/050447 United States
Oligomers with improved off-target profile PCT/2013/050308 Australia
Oligomers with improved off-target profile PCT/2013/050308 Canada
Oligomers with improved off-target profile PCT/2013/050308 Europe
Oligomers with improved off-target profile PCT/2013/050308 India
Oligomers with improved off-target profile PCT/2013/050308 China
Oligomers with improved off-target profile PCT/2013/050308 Japan
Oligomers with improved off-target profile PCT/2013/050308 United States
